Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 16;7(7):bvad081.
doi: 10.1210/jendso/bvad081. eCollection 2023 Jun 5.

Periostin in Osteoporosis and Cardiovascular Disease

Marie-Eva Pickering  1 , Charlotte Oris  2 , Roland Chapurlat  3   4
Affiliations
Review

Periostin in Osteoporosis and Cardiovascular Disease

Marie-Eva Pickering et al. J Endocr Soc. .

Abstract

Context: Osteoporosis (OP) and cardiovascular disease (CVD), prevalent disorders worldwide, often coexist and share common risk factors. The identification of common biomarkers could significantly improve patients' preventive care.

Objectives: The objectives are 1, to review periostin (Postn) involvement in osteoporosis and in CVD, and 2, identify if Postn could be a common biomarker.

Design: This is a scoping review on Postn in OP and CVD.

Methods: Databases were searched, in vitro and in vivo, for publications in English on Postn, bone, and the cardiovascular system, with no limit regarding publication date.

Results: Postn appears as a key factor in OP and CVD. Its role as a potential biomarker in both pathologies is described in recent studies, but a number of limitations have been identified.

Conclusions: Current evidence provides fragmented views on Postn in OP and CVD and does not encapsulate Postn as a common pivotal thread linking these comorbidities. A number of gaps impede highlighting Postn as a common biomarker. There is room for future basic and clinical research with Postn as a marker and a target to provide new therapeutic options for aging patients with concomitant OP and CVD.

Keywords: bone; cardiovascular; periostin.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Factors regulating periostin (POSTN) expression. Transcription factors (as Twist), chemokines, mechanical stress, traumatism, or inflammation regulate the expression of POSTN. POSTN acts on bone via its regulation of Wnt/βcatenin pathway. It is also a ligand for integrin αvβ3. Therapeutic strategies involving POSTN include sartans and antibodies. Losartan is an angiotensin II type 1 receptor (AT1) blocker that decreases osteoclast differentiation and activity; the inhibition of POSTN expression could be one explanation. POSTN antibodies have also been developed.
Figure 2.
Figure 2.
PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram.
See this image and copyright information in PMC

References

    1. Peacock M, Turner CH, Econs MJ, Foroud T. Genetics of osteoporosis. Endocr Rev. 2002;23(3):303‐326. - PubMed
    1. Vinkhuyzen AAE, Wray NR, Yang J, Goddard ME, Visscher PM. Estimation and partition of heritability in human populations using whole-genome analysis methods. Annu Rev Genet. 2013;47(1):75‐95. - PMC - PubMed
    1. Laroche M, Pécourneau V, Blain H, et al. . Osteoporosis and ischemic cardiovascular disease. Joint Bone Spine. 2017;84(4):427‐432. - PubMed
    1. Szulc P, Samelson EJ, Kiel DP, et al. . Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone MinerRes. 2009;24(12):2023‐2031. - PMC - PubMed
    1. Szulc P, Samelson EJ, Sornay-Rendu E, Chapurlat R, Kiel DP. Severity of aortic calcification is positively associated with vertebral fracture in older men—a densitometry study in the STRAMBO cohort. Osteoporos Int. 2013;24(4):1177‐1184. - PMC - PubMed

LinkOut - more resources